0.3905
price up icon2.63%   0.01
after-market After Hours: .37 -0.0205 -5.25%
loading
Passage Bio Inc stock is traded at $0.3905, with a volume of 94,985. It is up +2.63% in the last 24 hours and up +29.30% over the past month. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
See More
Previous Close:
$0.3805
Open:
$0.3767
24h Volume:
94,985
Relative Volume:
0.40
Market Cap:
$29.80M
Revenue:
-
Net Income/Loss:
$-68.80M
P/E Ratio:
-0.3338
EPS:
-1.17
Net Cash Flow:
$-59.06M
1W Performance:
-14.83%
1M Performance:
+29.30%
6M Performance:
-36.14%
1Y Performance:
-59.11%
1-Day Range:
Value
$0.3767
$0.3923
1-Week Range:
Value
$0.375
$0.46
52-Week Range:
Value
$0.257
$1.33

Passage Bio Inc Stock (PASG) Company Profile

Name
Name
Passage Bio Inc
Name
Phone
(267) 866-0312
Name
Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Name
Employee
60
Name
Twitter
@passage_bio
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
PASG's Discussions on Twitter

Compare PASG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PASG
Passage Bio Inc
0.3905 29.80M 0 -68.80M -59.06M -1.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
448.40 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
513.58 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
312.32 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
537.92 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
252.78 28.51B 3.81B -644.79M -669.77M -6.24

Passage Bio Inc Stock (PASG) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-29-24 Resumed Wedbush Outperform
Sep-03-24 Initiated Rodman & Renshaw Buy
Mar-08-22 Downgrade JP Morgan Overweight → Neutral
Jan-19-22 Downgrade Goldman Buy → Neutral
Jul-01-21 Initiated Raymond James Outperform
Jun-15-21 Initiated BTIG Research Buy
Mar-04-21 Upgrade Goldman Neutral → Buy
Feb-04-21 Initiated Guggenheim Buy
Jan-25-21 Initiated Wedbush Outperform
Jan-04-21 Upgrade JP Morgan Neutral → Overweight
Dec-11-20 Initiated Citigroup Neutral
Aug-14-20 Downgrade JP Morgan Overweight → Neutral
Jun-25-20 Downgrade Goldman Buy → Neutral
Mar-25-20 Initiated Chardan Capital Markets Buy
Mar-24-20 Initiated Cowen Outperform
Mar-24-20 Initiated Goldman Buy
Mar-24-20 Initiated JP Morgan Overweight
View All

Passage Bio Inc Stock (PASG) Latest News

pulisher
Jun 14, 2025

Passage Bio, Inc. (NASDAQ:PASG) Stake Cut by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

10,923 Shares in Annovis Bio, Inc. (NYSE:ANVS) Bought by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

American Battery Technology (NASDAQ:ABAT) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Has $36,000 Stake in Passage Bio, Inc. (NASDAQ:PASG) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Semrush Holdings, Inc. (NASDAQ:SEMR) Shares Purchased by Bank of America Corp DE - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Lumina Gold (OTCMKTS:LMGDF) Trading Down 0.3% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Obsidian Energy (OTCMKTS:OBELF) Shares Up 2.7% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Carbios SAS (OTCMKTS:COOSF) Stock Price Up 5% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Suncrest Bank (OTCMKTS:SBKK) Shares Up 1% – Should You Buy? - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Color Star Technology (NASDAQ:CSCW) Trading 0.5% Higher – Here’s What Happened - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Inventiva (NASDAQ:IVA) Stock Price Up 0.8% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Fury Gold Mines (NYSEAMERICAN:FURY) Stock Price Down 3.2% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Nano Magic (OTCMKTS:NMGX) Shares Up 5% – What’s Next? - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Grows Holdings in Passage Bio, Inc. (NASDAQ:PASG) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews

Jun 06, 2025
pulisher
Jun 06, 2025

Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace

Jun 06, 2025
pulisher
Jun 05, 2025

Passage Bio, Inc. (NASDAQ:PASG) Shares Purchased by Northern Trust Corp - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Has $1.93 Million Stake in Haleon plc (NYSE:HLN) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Passage Bio Adopts Key Proposals at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Position in Talkspace, Inc. (NASDAQ:TALK) - Defense World

May 30, 2025
pulisher
May 29, 2025

D. E. Shaw & Co. Inc. Increases Holdings in 908 Devices Inc. (NASDAQ:MASS) - Defense World

May 29, 2025
pulisher
May 21, 2025

VintaBio Showcases Breakthrough Gene Therapy Manufacturing Platform - MyChesCo

May 21, 2025
pulisher
May 20, 2025

Metachromatic Leukodystrophy Pipeline 2025: Groundbreaking - openPR.com

May 20, 2025
pulisher
May 20, 2025

GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com

May 20, 2025
pulisher
May 20, 2025

Guggenheim Adjusts Price Target for Passage Bio (PASG) | PASG St - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Cubist Systematic Strategies LLC Grows Holdings in Intevac, Inc. (NASDAQ:IVAC) - Defense World

May 20, 2025
pulisher
May 18, 2025

Cabaletta Bio Updates Progress on RESET-Myositis Trial and Regulatory Milestones - MyChesCo

May 18, 2025
pulisher
May 18, 2025

Passage Bio Reports Q1 2025 Financial Results and Highlights Progress in Gene Therapy Development - MSN

May 18, 2025
pulisher
May 18, 2025

Wedbush Issues Pessimistic Estimate for Passage Bio Earnings - Defense World

May 18, 2025
pulisher
May 16, 2025

Gm1 Gangliosidosis Treatment Market in 2025 Detailed Study - openPR.com

May 16, 2025
pulisher
May 16, 2025

Dimensional Fund Advisors LP Has $1.14 Million Stock Holdings in Traeger, Inc. (NYSE:COOK) - Defense World

May 16, 2025
pulisher
May 16, 2025

TransAct Technologies Incorporated (NASDAQ:TACT) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 16, 2025
pulisher
May 16, 2025

Passage Bio, Inc. (NASDAQ:PASG) Shares Acquired by Tower Research Capital LLC TRC - Defense World

May 16, 2025
pulisher
May 16, 2025

Tower Research Capital LLC TRC Acquires 7,927 Shares of The E.W. Scripps Company (NASDAQ:SSP) - Defense World

May 16, 2025
pulisher
May 14, 2025

Braskem Marks 15 Years of I’m green Bio-Based Portfolio with Expanded Production - MyChesCo

May 14, 2025
pulisher
May 14, 2025

Passage Bio Reports Q1 2025 Financial Results - TipRanks

May 14, 2025
pulisher
May 13, 2025

Wedbush Adjusts Price Target on Passage Bio to $3 From $4, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Passage Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Passage Bio Q1 Income From Operations USD -16.459 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Passage Bio (PASG) Advances Phase 1/2 Trial for PBFT02, Eyes Fut - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Passage BIO, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Passage Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ISPOR 2025 - The Manila Times

May 13, 2025
pulisher
May 11, 2025

Passage Bio (PASG) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

2025 Q1 Job Market Report: Quarterly Job Postings Live Declined as Applications Spiked - BioSpace

May 08, 2025
pulisher
May 01, 2025

Annovis Bio Appoints Hui Liu as Director of Biostatistics - MyChesCo

May 01, 2025
pulisher
Apr 30, 2025

Orbimed Advisors LLC Reduces Stake in Passage Bio Inc: A Strategic Portfolio Adjustment - GuruFocus

Apr 30, 2025

Passage Bio Inc Stock (PASG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Passage Bio Inc Stock (PASG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
ORBIMED ADVISORS LLC
10% Owner
Apr 22 '25
Sale
0.34
78,049
26,537
6,807,523
ORBIMED ADVISORS LLC
10% Owner
Apr 24 '25
Sale
0.32
68,195
21,822
6,650,000
ORBIMED ADVISORS LLC
10% Owner
Apr 17 '25
Sale
0.33
77,090
25,440
6,885,572
ORBIMED ADVISORS LLC
10% Owner
Apr 16 '25
Sale
0.33
61,638
20,341
6,962,662
ORBIMED ADVISORS LLC
10% Owner
Apr 15 '25
Sale
0.38
10,326
3,924
7,024,300
$21.56
price down icon 2.13%
$34.91
price up icon 1.01%
$20.16
price up icon 1.56%
$99.46
price down icon 0.82%
$104.40
price down icon 0.54%
biotechnology ONC
$252.78
price down icon 0.52%
Cap:     |  Volume (24h):